In STEMI care, restoring blood flow quickly is the priority. If fibrinolytics are contraindicated, primary PCI is the preferred reperfusion method, provided it can be done promptly—ideally within about 90 minutes of first medical contact and by a skilled interventional team at an experienced facility. This approach offers mechanical revascularization with higher success rates and tends to have better outcomes, including lower mortality and fewer bleeding complications, compared with thrombolysis when the procedure can be completed in time. If PCI cannot be performed within that window, fibrinolysis may be considered if there are no contraindications, but the emphasis remains on achieving rapid reperfusion via PCI when feasible.

In non-shockable cardiac arrest rhythms, the priority is to restore and maintain perfusion while addressing treatable underlying problems. High-quality CPR with minimal interruptions keeps blood flowing to the brain and heart, while actively identifying and treating reversible causes (the Hs and Ts) such as hypoxia, hypovolemia, electrolyte disturbances, acidosis, toxins, tamponade, tension pneumothorax, and thrombosis. Epinephrine 1 mg IV/IO every 3-5 minutes is given to improve perfusion pressures during CPR and increase the chance of ROSC. Defibrillation isn’t effective for asystole or pulseless electrical activity, so delivering a shock would not help and delays ongoing CPR and cause treatment gaps. Waiting for ROSC without continuing CPR and addressing reversible causes also reduces survival chances.

During CPR, how you ventilate matters because each rapid breath increases intrathoracic pressure and reduces the amount of blood returning to the heart. This drop in venous return lowers preload and, more importantly, decreases coronary perfusion pressure—the pressure driving blood to the heart muscle between compressions. When coronary perfusion pressure falls, the chance of returning to a sustainable heartbeat (ROSC) goes down. That’s why minimizing hyperventilation is important: you want enough ventilation to oxygenate without pushing in air so forcefully or so rapidly that it impedes blood flow to the heart and brain. Hyperventilation can also cause hypocapnia and cerebral vasoconstriction, further reducing brain perfusion. The other statements aren’t correct because overly rapid ventilation doesn’t improve perfusion or ROSC, and it doesn’t inherently boost defibrillation success.

ECMO is used as a rescue therapy in ACLS when the heart and lungs cannot be supported adequately by standard resuscitation, buying time to treat the reversible problem and stabilize the patient. This approach, sometimes called ECPR, provides both circulatory support and oxygenation, effectively bridging to recovery or to definitive treatment. It is not a routine first-line step in every arrest, and it is not absent from ACLS protocols; rather, it is a specialized option reserved for cases where conventional therapies have failed to restore circulation or stabilize cardiogenic shock, and only if a capable center with the necessary resources, expertise, and rapid access is available. It is more than simply “used after failure”; it requires a demonstrated reversible cause, favorable timing, and a facility equipped to deploy ECMO quickly and safely.

During CPR for a non-shockable rhythm, the goal is to maintain perfusion to the heart and brain while continuing high-quality chest compressions. Epinephrine is given to boost coronary and cerebral perfusion pressure, and the standard practice is to administer 1 mg IV/IO every 3 to 5 minutes and repeat as CPR continues. This 3–5 minute interval fits with the typical CPR cycle, usually about two minutes of compressions before reassessment. Shorter intervals (like every 1–2 minutes) would be too frequent and longer gaps (like every 5–7 minutes) could miss opportunities to improve perfusion. Therefore, the best interval is every 3–5 minutes.